Acute lymphoblastic leukemia (ALL) is generally regarded as a clonal disease in which a single abnormal progenitor cell gives rise to neoplastic progeny. Five of 463 cases of childhood ALL with adequately banded leukemic cells were found to have two cytogenetically independent cell populations. In addition, two of the four cases tested had more than two rearranged immunoglobulin genes and (or) T cell receptor genes. To investigate the clonality of these unusual leukemias, we examined the neoplastic cells for X-linked markers extrinsic to the disease. Leukemic cells from each of the three patients heterozygous for an X-linked, restriction fragment length polymorphism showed a single active parental allele, suggesting that both apparently independent cell populations developed from a common progenitor. These cases provide evidence that leukemogenesis involves a multistep process of mutation and suggest that karyotypic abnormalities may be a late event of malignant transformation.
Introduction
Leukemias and lymphomas are generally thought to be clonal in origin, developing from a single, abnormal progenitor cell capable of expansion by indefinite self-renewal. Evidence to support this concept comes from several different lines of research, including glucose-6-phosphate dehydrogenase (G6PD)' enzyme studies, recombinant DNA analysis based on restriction fragment length polymorphisms (RFLPs), determination of T cell receptor gene or immunoglobulin gene rearrangements, demonstration of immunoglobulin idiotypes and light-chain types in B cell malignancies, and karyotype analysis (see reference 1 for review).
In G6PD studies, the unicellular development of neoplasias can be demonstrated by finding a single type of G6PD in the malignant cells of heterozygous patients who have a double-enzyme pattern in their normal tissues (1) . However, only cells from female patients heterozygous for the X chromosome-linked G6PD gene can be analyzed. The largest single study of this type in childhood acute lymphoblastic leukemia (ALL) consisted of 19 girls heterozygous for G6PD (2) . Determination of the methylation patterns of X-linked RFLPs in heterozygous females is another sensitive method of analysis based on the same principle (3) . From differences in the arrangement of DNA in immunoglobulin genes in two subpopulations ofcells, Sklar and associates (4) identified four cases of "biclonal" B cell lymphoma. Similarly, Weiss and co-workers (5) suggested that some patients with lymphomatoid papulosis, a clinically benign but histologically malignant skin disease, have a "multiclonal" disorder. This idea was based on the patterns ofT cell receptor gene rearrangement found in biopsy specimens from different sites in a single patient and on the presence of three rearranged bands identified by analysis of T cell receptor genes from other patients. Kitchingman et al. (6) , using a CQ heavy-chain immunoglobulin gene probe, found more than two rearranged bands in 18 of 93 cases of B cell precursor ALL. However, these results may not indicate biclonality but rather somatic hypermutation in the rearranged immunoglobulin genes (7), replacement of rearranged V regions at the VD joint by 5' V regions (8, 9), or clonal evolution involving continued rearrangement ofthe immunoglobulin or T cell receptor genes after malignant transformation (10) (11) (12) .
Detection of completely unrelated stem lines in the analysis of leukemic cell karyotypes has been regarded as evidence of biclonal or multiclonal disease. At the Fourth International Workshop on Chromosomes in Leukemia (13), stem lines were considered related when they contained at least one change (numerical or structural) in common, and unrelated when not even one chromosomal change was common to all the lines. Although multiple leukemic lines have been found in approximately one-fourth of cases of ALL at diagnosis (14) (15) (16) , only rarely have they appeared to represent "independent" lines (15). The presumed biclonal nature of cases with seemingly independent stem lines has not been substantiated by other genetic or molecular approaches.
With improved banding techniques, > 90% of newly diagnosed cases of ALL can be identified as having clonal chromosome abnormalities (17, 18). Using such methods, we were able to detect two apparently independent stem lines coexisting in newly diagnosed cases of ALL. region of the HPRT locus (31) were used as hybridization probes..
Results
The five girls with two "independent" leukemic stem lines at diagnosis were 3-1 1 yr old, and had presenting leukocyte counts of 3.1-246 X 109/liter, hemoglobin levels of 3.8-10.4 g/dl, and platelet counts of 8-85 X 109/liter (Table I ). Patient I presented with an anterior mediastinal mass; none of the patients had initial central nervous system leukemia. The blast cells in four cases were classified as FAB Ll, and in one case as FAB L2 (Table II) . Immunologic subtypes of ALL were T cell in patient 1, pre-B cell in patient 4, and common in patients 2, 3, and 5. All cases lacked cytochemical evidence of myeloid differentiation at diagnosis. When cases were examined for reactivity with monoclonal antibodies against myeloid-associated differentiation markers, 70% of the blast cells from patient 3 expressed MY9 without other myeloid markers. By dual immunofluorescence study, the blast cells from patient 3 were demonstrated to coexpress B4 and MY9 antigens (Fig. 1) . No leukemic cells were stored for patient 1. Fig. 2 cases are readily distinguished from leukemias that show progressive karyotypic changes within the same clone (clonal evolution) (13) or bilineal features in the presence of a single karyotype. Clonal evolution, in which a leukemic sample contains two or more sublines with related chromosomal abnormalities, is a relatively common finding in ALL; almost one- fourth of the cases tested have shown evidence of this process at diagnosis (14-16). Bilineal leukemia, in which populations of lymphoblasts and myeloblasts coexist within the same patient, is well documented but is far less frequent than cases showing clonal evolution (33-35). Leukemic transformation of a multipotential progenitor for both lymphoid and myeloid cells could explain the simultaneous occurrence oftwo phenotypically distinct but karyotypically similar cell populations (36). In this respect, Philadelphia chromosome-positive chronic myelogenous leukemia and some cases of acute myeloid leukemia and Philadelphia chromosome-positive ALL have been shown to involve multipotent stem cells capable of differentiation along either a myeloid or lymphoid pathway (37) (38) (39) .
Although the coexistence ofcytogenetically unrelated stem lines has been regarded as evidence of biclonal disease (13) , this concept has not been substantiated by molecular clonal analyses. X chromosome-linked markers have been valuable in the study of clonal development of cancers (1) (2) (3) 29) . As a result of random stable inactivation of one of the two X chromosomes in female somatic cells, normal tissues in women are 1 mosaics, containing some cells with an active paternal X chromosome and other cells with an active maternal X chromosome. By contrast, proliferations that develop clonally are composed of cells expressing the same parental X chromosome. To evaluate the clonal or biclonal nature of leukemia with two cytogenetically independent stem lines, we studied four of our cases with X-inactivation markers. Leukemic cells from each of the three patients heterozygous for an X-linked RFLP showed a single active parental allele. It is possible that a cytogenetic abnormality common to all leukemic cells in each patient is not detectable by the techniques that we used or was present initially and subsequently lost from both sublines. It is theoretically possible that a subline diverged from the parent clone by complex rearrangements that recreated apparently normal chromosomes while producing additional karyotypic changes. However, the most likely explanation is that the patient's leukemias developed clonally from cytogenetically normal but unstable progenitors and that the two apparently unrelated abnormal karyotypes arose by clonal evolution. A similar pathogenesis has been proposed for a patient with myelodysplastic syndrome (40). In this regard, clonal remissions, as indicated by the finding ofone or predominantly one G6PD type, have been found in some cases of acute myeloid leukemia, despite evidence in one patient that a cytogenetically abnormal clone disappeared (41, 42). This finding suggests a multistep leukemogenesis with progression from a neoplastic, but cytogenetically normal, progenitor to a karyotypically abnormal, overtly leukemic clone. However, since for each case there is a 50% chance that two independent clones will express the same allele, there remains a 1 in 8 probability that these three cases are truly biclonal. Additional leukemias with more than one cytogenetically distinct line should be studied to address this issue with statistical confidence.
We have previously reported leukemias that had completely different karyotypes at diagnosis and at relapse (22). To explain this finding, we suggested either that two clonally distinct abnormal lines existed at diagnosis but were overlooked during cytogenetic studies or that a second leukemic transformation event had occurred. In light of results from the present study, we believe that some of these cases in fact arose from clonal evolution rather than transformation of separate lymphoid progenitors. Patient Although the biologic significance of expression of a myeloid marker, MY9, in the blast cells of patient 3 is unknown, it further illustrates the biologic heterogeneity of leukemia. Such mixed-lineage expression has been explained on the basis of (a) malignant transformation of a pluripotent stem cell or a rarely detected progenitor cell or (b) aberrant gene expression resulting from a leukemogenic event (47) (48) (49) (50) .
In summary, this study suggests that cytogenetically independent cell populations coexisting in individual patients with ALL arise from a cytogenetically normal progenitor and represent a form of clonal evolution. Our findings support the concept that leukemogenesis involves multiple genetic events. They also suggest that some cases of so-called lineage switch in acute leukemia (32) may in fact represent subclonal selection and evolution due to the pressure of chemotherapy. Further studies of such cases may improve our understanding of leukemogenesis and clarify mechanism(s) of lineage conversion.
